What We're Reading: Page 322
Industry reads hand-picked by our editors
Jun 16, 2016
Jun 15, 2016
Jun 14, 2016
-
FierceBiotech
FDA overrides adcomm, shoots down KemPharm’s opioid
-
MIT Technology Review
Gene Therapy Is Curing Hemophilia
-
Reuters
Regulator says too many drugmakers chasing same cancer strategy
-
Stat
Novartis, Colombia face off over cancer drug cost
Jun 13, 2016
-
Forbes
Ex-Valeant CEO's pay structure may have increased dangerous risk-taking, study says
-
Science Daily
Aspirin may increase survival after colon cancer
-
Modern Healthcare
As views shift on opioids, patients and providers find few other options for managing pain
-
BioSpace
Jennifer Lawrence signs on to play Elizabeth Holmes in movie about embattled Theranos
Jun 10, 2016
-
PharmaLive
Pharmaceutical companies that give back and donate to medical relief nonprofits
-
The Pharmaceutical Journal
How polypharmacy has become a medical burden worldwide
-
BioWorld
Will biopharma deal-making brave the headwinds or retreat to 'wait-and-see'?
-
PharmExec.com
Snapchat: A platform for pharma marketing?
Jun 09, 2016
-
Modern Healthcare
Biopharma plays offense to justify high price tags
-
The Wall Street Journal
Biogen CIO Matt Griffiths no longer with company
-
The Cannabist
Medical marijuana sellers in Canada continue despite crackdown
-
Nurse.com
Pharmaceutical companies continue to hike drug costs
Jun 08, 2016
-
Bloomberg BNA
Pharma deals under a microscope at FTC
-
Medical Marketing & Media
The CIO, reimagined for pharma
-
Chicago Tribune
Avenging Pharma Bro: Vermont demands drug firms justify price hikes
-
Financial Times
Pharma surge boosts UK manufacturing output